2002-2003 Phase III international multicenter clinical trial using Raptiva to treat patients with moderate to severe psoriasis.

2004-2005 Phase III international multicenter clinical trial using rifaximin with and without loperamide to treat patients with traveler’s diarrhea.

2006-2007 Phase II multicenter clinical trial using an E. coli vaccine to prevent traveler’s diarrhea. Phase III multicenter clinical trial using prulifloxacin to treat patients with traveler’s diarrhea.

2007-2008 Phase III multicenter clinical trial using prulifloxacin to treat patients with traveler’s diarrhea.

2009 Phase IV national multicenter clinical trial to treat bronchitis. MIMU. Study conducted in Cuernavaca, Mexico. Phase IV national multicenter clinical trial to treat pharyngitis. MPIMU. Study conducted in Cuernavaca, Mexico.

2009-2010 Phase III international multicenter clinical trial using an E. coli vaccine to prevent traveler’s diarrhea. Phase III multicenter clinical trial using rifaximin to prevent the onset of traveler’s diarrhea.

2012-2013 Phase IV national multicenter clinical trial evaluating a muscle relaxant and NSAID for muscle and joint pain. Study conducted in Cuernavaca, Mexico.

2013 – 2014 Phase III multicenter clinical trial evaluating Solithromycin PO to treat patients suffering from community-acquired pneumonia. Houston, Texas, USA.

2013 – 2014Phase III multicenter clinical trial evaluating Rifaximin to treat patients with diarrhea-predominant IBS. Study conducted in Houston, Texas, USA.

2013 – 2016 Multicenter phase III clinical trial evaluating aclidinium bromide on long-term cardiovascular safety and COPD exacerbations in patients with moderate to very severe COPD. Houston, Texas.

2014 Phase III international multicenter clinical trial using Favipiravir to treat uncomplicated influenza.

2014Phase III multicenter clinical trial evaluating Delafloxacin to treat patients with Gonorrhea. Houston, Texas.

2014 – 2015 Phase III clinical trial evaluating IV Solithromycin to treat patients suffering from community-acquired pneumonia. Houston, Texas.

2014 Phase III multicenter clinical trial evaluating a vaginally administered antibiotic to treat patients with bacterial vaginosis. Houston, Texas, USA.

2014 – 2015 Phase III multicenter clinical trial evaluating a medical device to diagnose Helicobacter pylori infection. Houston, Texas.

2015 Open-label study of Dolutegravir (DTG) or Efavirenz (EFV) for HIV-tuberculosis coinfection. Phase III clinical trial of a toxoid vaccine against Clostridium difficile in subjects at risk of C. Difficile infection. Phase III international multicenter clinical trial using an E. coli vaccine to prevent Clostridium difficile toxoid infection in subjects at risk of C. Difficile infection.

2015 – 2016 Phase III muticenter clinical trial evaluating Atrasentan in patients suffering from diabetic nephropathy. Houston, Texas.

2015-2017 Phase III international multicenter clinical trial using an E. coli vaccine to prevent Clostridium difficile toxoid infection in subjects at risk of C. Difficile infection.

2016 Phase III multicenter clinical trial evaluating mupirocin in patients suffering from impetigo. Study conducted in Cuernavaca, Mexico. Phase III clinical trial on the treatment of hypercholesterolemia.

2016-2018 Phase IIb multicenter clinical trial evaluating Arachmol in patients with NASH. Study conducted in Cuernavaca, Mexico.

2017 Phase III clinical trial on the treatment of arterial hypertension.

2017-2018 Phase III international multicenter clinical trial of an influenza vaccine for the pediatric population.

2017-2019 Phase II/III clinical trial evaluating ABP798 versus Rituximab in patients suffering from non-Hodgkin lymphoma. Study conducted in Cuernavaca, Mexico. Phase IV clinical trial evaluating a combination of bicarbonate and omeprazole in patients with GERD. Study conducted in Cuernavaca, Mexico.

2017-2021 Phase II clinical trial evaluating Cenicriviroc in patients suffering from NASH with liver fibrosis. Study conducted in Cuernavaca, Mexico. Phase III clinical trial on the treatment of arterial hypertension.

2017-2022 Phase IV clinical trial for the treatment of hepatitis C (Sofosbuvir).

2017-2024 Phase III international multicenter clinical trial on the treatment of diabetes mellitus in the pediatric and adolescent population. Phase IV clinical trial for the dengue vaccine (Dengvaxia).

2018-2019 Phase III clinical trial evaluating RJ-0265 for the treatment of onychomycosis in adults. Study conducted in Cuernavaca, Mexico.

2018 – 2020 Phase III multicenter clinical trial evaluating Relamorelin for the treatment of diabetic gastroparesis. Houston, Texas.

2018 – 2020 Phase III multicenter clinical trial evaluating Pimodivir for the treatment of high-risk patients suffering from influenza infection. Study conducted in Houston, Texas.

2019-2020 Phase III clinical trial evaluating AAI101 for the treatment of complicated urinary tract infection in hospitalized patients. Study conducted in Cuernavaca, Mexico.

2019-2021 Phase III clinical trial evaluating Risanlizumab for the treatment of Crohn’s disease. Study conducted in Cuernavaca, Mexico. Phase III clinical trial evaluating SHP647 for the treatment of severe ulcerative colitis. Study conducted in Cuernavaca, Mexico.

2021-present Phase III international multicenter clinical trial for the treatment of COVID-19 in the pediatric population. Phase III international multicenter clinical trial for the treatment of COVID-19.

2021-2023 Phase III international multicenter clinical trial for the vaccine against respiratory syncytial virus in the pediatric population.

2022-2024 Phase III international multicenter clinical trial for the COVID-19 vaccine.

2023 Multicenter clinical trial to evaluate resveratrol as an adjunct to metformin for the management of prediabetes.

2022-2024 Phase 3 trial evaluating curcumin for Osteorathrosis. Study conducted in Cuernavaca, Mexico

2024-2024 Phase I trial studying Sisunatovir in pediatric patients with RSV infection. Study conducted in Cuernavaca, Mexico

2023-2025 Phase 3 trial evaluating Abrocitinib for the treatment of Atopic Dermatitis. Study conducted in Cuernavaca, Mexico

2023-2025 Phase 3 trial evaluating Cefepime / Zidebactam for the treatment of Pyelonephritis. Study conducted in Cuernavaca, Mexico